Skip to main content
Erschienen in: Journal of Neurology 12/2011

01.12.2011 | Original Communication

The role of 123I-FP-CIT-SPECT in the differential diagnosis of Parkinson and tremor syndromes: a critical assessment of 125 cases

verfasst von: Friederike Sixel-Döring, Knut Liepe, Brit Mollenhauer, Ellen Trautmann, Claudia Trenkwalder

Erschienen in: Journal of Neurology | Ausgabe 12/2011

Einloggen, um Zugang zu erhalten

Abstract

123I-FP-CIT-SPECT is useful in the differential diagnosis of Parkinson’s disease (PD) and tremor syndromes. Recently, there have been reports on normal nigrostriatal uptake of radio ligands in PD patients, referred to as scans without evidence of dopaminergic deficit (SWEDDs). Furthermore, a dopaminergic deficit has been described in some cases of different tremor types. We sought to clarify the occurrence of SWEDDs in PD and a possible association of various tremor types with PD. We performed a retrospective case analysis of 125 patients with diagnostically uncertain Parkinsonian or non-Parkinsonian tremor syndromes with clinical assessments and 123I-FP-CIT-SPECT. A total of 36/40 (90%) patients with the predominant clinical feature of a postural and/or kinetic tremor showed normal DAT SPECT; 73/85 (86%) with predominant clinical symptoms of PD showed abnormal DAT SPECT with lower overall radio ligand uptake and a significant asymmetry contralateral to the clinically more affected side. In all, 4/40 (10%) of non-Parkinsonian tremor patients had abnormal DAT SPECT, but no corresponding asymmetry of radio ligand uptake. Probable essential tremor was considered clinically in follow-up assessments although final diagnosis of these four tremor cases remains inconclusive. A total of 12/85 (14%) clinically suspected PD patients had normal DAT SPECT (SWEDDs). Clinical reassessment identified two patients with dystonic tremor. Five patients with a positive response to levodopa remained unclear. In four cases of suspected PD with normal DAT SPECT, non-neurologic diseases were identified. One case showed a complete and spontaneous remission of symptoms. DAT SPECT offers an objective method to confirm or exclude a dopaminergic deficit in tremor predominant parkinsonism for clinically inconclusive cases. There was no evidence of a decrease in DAT binding in the majority of patients with postural and/or kinetic tremor. The striatal asymmetry index is a further helpful tool for differentiating PD from non-PD tremor syndromes.
Literatur
1.
Zurück zum Zitat Booij J, Hemelaar TG, Speelman JD, de Bruin K, Janssen AG, van Royen EA (1999) One-day protocol for imaging of the nigrostriatal dopaminergic pathway in Parkinson’s disease by [123I]FPCIT SPECT. J Nucl Med 40:753–761PubMed Booij J, Hemelaar TG, Speelman JD, de Bruin K, Janssen AG, van Royen EA (1999) One-day protocol for imaging of the nigrostriatal dopaminergic pathway in Parkinson’s disease by [123I]FPCIT SPECT. J Nucl Med 40:753–761PubMed
2.
Zurück zum Zitat Antonini A, Benti R, De Notaris R et al (2003) 123I-Ioflupane/SPECT binding to striatal dopamine transporter (DAT) uptake in patients with Parkinson’s disease, multiple system atrophy, and progressive supranuclear palsy. Neurol Sci 24:149–150PubMedCrossRef Antonini A, Benti R, De Notaris R et al (2003) 123I-Ioflupane/SPECT binding to striatal dopamine transporter (DAT) uptake in patients with Parkinson’s disease, multiple system atrophy, and progressive supranuclear palsy. Neurol Sci 24:149–150PubMedCrossRef
3.
Zurück zum Zitat Benamer TS, Patterson J, Grosset DG et al (2000) Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study group. Mov Disord 15:503–510PubMedCrossRef Benamer TS, Patterson J, Grosset DG et al (2000) Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study group. Mov Disord 15:503–510PubMedCrossRef
4.
Zurück zum Zitat Catafau AM, Tolosa E (2004) Impact of dopamine transporter SPECT using 123I-Ioflupane on diagnosis and management of patients with clinically uncertain parkinsonian syndromes. Mov Disord 19:1175–1182PubMedCrossRef Catafau AM, Tolosa E (2004) Impact of dopamine transporter SPECT using 123I-Ioflupane on diagnosis and management of patients with clinically uncertain parkinsonian syndromes. Mov Disord 19:1175–1182PubMedCrossRef
5.
Zurück zum Zitat Marshall V, Grosset DG (2003) Role of dopamine transporter imaging in the diagnosis of atypical tremor disorders. Mov Disord 18(Suppl 7):S22–S27PubMedCrossRef Marshall V, Grosset DG (2003) Role of dopamine transporter imaging in the diagnosis of atypical tremor disorders. Mov Disord 18(Suppl 7):S22–S27PubMedCrossRef
6.
Zurück zum Zitat Plotkin M, Amthauer H, Klaffke S et al (2005) Combined 123I-FP-CIT and 123I-IBZM SPECT for the diagnosis of parkinsonian syndromes: study on 72 patients. J Neural Transm 112:677–692PubMedCrossRef Plotkin M, Amthauer H, Klaffke S et al (2005) Combined 123I-FP-CIT and 123I-IBZM SPECT for the diagnosis of parkinsonian syndromes: study on 72 patients. J Neural Transm 112:677–692PubMedCrossRef
7.
Zurück zum Zitat Filippi L, Manni C, Pierantozzi M et al (2005) 123I-FP-CIT semi-quantitative SPECT detects preclinical bilateral dopaminergic deficit in early Parkinson’s disease with unilateral symptoms. Nucl Med Commun 26:421–426PubMedCrossRef Filippi L, Manni C, Pierantozzi M et al (2005) 123I-FP-CIT semi-quantitative SPECT detects preclinical bilateral dopaminergic deficit in early Parkinson’s disease with unilateral symptoms. Nucl Med Commun 26:421–426PubMedCrossRef
8.
Zurück zum Zitat Booij J, Tissingh G, Boer GJ et al (1997) [123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson’s disease. J Neurol Neurosurg Psychiatry 62:133–140PubMedCrossRef Booij J, Tissingh G, Boer GJ et al (1997) [123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson’s disease. J Neurol Neurosurg Psychiatry 62:133–140PubMedCrossRef
9.
Zurück zum Zitat Booij J, Speelman JD, Horstink MW, Wolters EC (2001) The clinical benefit of imaging striatal dopamine transporters with [123I]FP-CIT SPET in differentiating patients with presynaptic parkinsonism from those with other forms of parkinsonism. Eur J Nucl Med 28:266–272PubMedCrossRef Booij J, Speelman JD, Horstink MW, Wolters EC (2001) The clinical benefit of imaging striatal dopamine transporters with [123I]FP-CIT SPET in differentiating patients with presynaptic parkinsonism from those with other forms of parkinsonism. Eur J Nucl Med 28:266–272PubMedCrossRef
10.
Zurück zum Zitat Jennings DL, Seibyl JP, Oakes D, Eberly S, Murphy J, Marek K (2004) (123I) Beta-CIT and single-photon emission computed tomographic imaging vs clinical evaluation in parkinsonian syndrome: unmasking an early diagnosis. Arch Neurol 61:1224–1229PubMedCrossRef Jennings DL, Seibyl JP, Oakes D, Eberly S, Murphy J, Marek K (2004) (123I) Beta-CIT and single-photon emission computed tomographic imaging vs clinical evaluation in parkinsonian syndrome: unmasking an early diagnosis. Arch Neurol 61:1224–1229PubMedCrossRef
11.
Zurück zum Zitat Doepp F, Plotkin M, Siegel L et al (2008) Brain parenchyma sonography and 123I-FP-CIT SPECT in Parkinson’s disease and essential tremor. Mov Disord 23:405–410PubMedCrossRef Doepp F, Plotkin M, Siegel L et al (2008) Brain parenchyma sonography and 123I-FP-CIT SPECT in Parkinson’s disease and essential tremor. Mov Disord 23:405–410PubMedCrossRef
12.
Zurück zum Zitat Schneider SA, Edwards MJ, Mir P et al (2007) Patients with adult-onset dystonic tremor resembling parkinsonian tremor have scans without evidence of dopaminergic deficit (SWEDDs). Mov Disord 22:2210–2215PubMedCrossRef Schneider SA, Edwards MJ, Mir P et al (2007) Patients with adult-onset dystonic tremor resembling parkinsonian tremor have scans without evidence of dopaminergic deficit (SWEDDs). Mov Disord 22:2210–2215PubMedCrossRef
13.
Zurück zum Zitat Shahed J, Jankovic J (2007) Exploring the relationship between essential tremor and Parkinson’s disease. Parkinsonism Relat Disord 13:67–76PubMedCrossRef Shahed J, Jankovic J (2007) Exploring the relationship between essential tremor and Parkinson’s disease. Parkinsonism Relat Disord 13:67–76PubMedCrossRef
14.
Zurück zum Zitat Yahr MD, Orosz D, Purohit DP (2003) Co-occurrence of essential tremor and Parkinson’s disease: clinical study of a large kindred with autopsy findings. Parkinsonism Relat Disord 9:225–231PubMedCrossRef Yahr MD, Orosz D, Purohit DP (2003) Co-occurrence of essential tremor and Parkinson’s disease: clinical study of a large kindred with autopsy findings. Parkinsonism Relat Disord 9:225–231PubMedCrossRef
15.
Zurück zum Zitat Louis ED, Levy G, Mejia-Santana H et al (2003) Risk of action tremor in relatives of tremor-dominant and postural instability gait disorder PD. Neurology 61:931–936PubMed Louis ED, Levy G, Mejia-Santana H et al (2003) Risk of action tremor in relatives of tremor-dominant and postural instability gait disorder PD. Neurology 61:931–936PubMed
16.
Zurück zum Zitat Ondo WG, Lai D (2005) Olfaction testing in patients with tremor-dominant Parkinson’s disease: is this a distinct condition? Mov Disord 20:471–475PubMedCrossRef Ondo WG, Lai D (2005) Olfaction testing in patients with tremor-dominant Parkinson’s disease: is this a distinct condition? Mov Disord 20:471–475PubMedCrossRef
17.
Zurück zum Zitat Pahwa R, Koller WC (1993) Is there a relationship between Parkinson’s disease and essential tremor? Clin Neuropharmacol 16:30–35PubMedCrossRef Pahwa R, Koller WC (1993) Is there a relationship between Parkinson’s disease and essential tremor? Clin Neuropharmacol 16:30–35PubMedCrossRef
18.
Zurück zum Zitat Geraghty JJ, Jankovic J, Zetusky WJ (1985) Association between essential tremor and Parkinson’s disease. Ann Neurol 17:329–333PubMedCrossRef Geraghty JJ, Jankovic J, Zetusky WJ (1985) Association between essential tremor and Parkinson’s disease. Ann Neurol 17:329–333PubMedCrossRef
19.
Zurück zum Zitat Chaudhuri KR, Buxton-Thomas M, Dhawan V, Peng R, Meilak C, Brooks DJ (2005) Long duration asymmetrical postural tremor is likely to predict development of Parkinson’s disease and not essential tremor: clinical follow-up study of 13 cases. J Neurol Neurosurg Psychiatry 76:115–117PubMedCrossRef Chaudhuri KR, Buxton-Thomas M, Dhawan V, Peng R, Meilak C, Brooks DJ (2005) Long duration asymmetrical postural tremor is likely to predict development of Parkinson’s disease and not essential tremor: clinical follow-up study of 13 cases. J Neurol Neurosurg Psychiatry 76:115–117PubMedCrossRef
20.
Zurück zum Zitat Louis ED, Honig LS, Vonsattel JP, Maraganore DM, Borden S, Moskowitz CB (2005) Essential tremor associated with focal nonnigral Lewy bodies: a clinicopathologic study. Arch Neurol 62:1004–1007PubMedCrossRef Louis ED, Honig LS, Vonsattel JP, Maraganore DM, Borden S, Moskowitz CB (2005) Essential tremor associated with focal nonnigral Lewy bodies: a clinicopathologic study. Arch Neurol 62:1004–1007PubMedCrossRef
21.
Zurück zum Zitat Marek K, Jennings D, Seibyl J (2005) Long-term follow-up of patients with scans without evidence of dopaminergic deficit (SWEDD) in the ELLDOPA study. Neurology 64:A274 (Abstract) Marek K, Jennings D, Seibyl J (2005) Long-term follow-up of patients with scans without evidence of dopaminergic deficit (SWEDD) in the ELLDOPA study. Neurology 64:A274 (Abstract)
22.
Zurück zum Zitat Marek K, Seibyl J, Parkinson’s Study Group (2003) β-CIT scans without evidence of dopaminergic deficit (SWEDD) in the ELLDOPA-CIT and CALM-CIT study: long-term imaging assessment. Neurology 60:A298 (Abstract) Marek K, Seibyl J, Parkinson’s Study Group (2003) β-CIT scans without evidence of dopaminergic deficit (SWEDD) in the ELLDOPA-CIT and CALM-CIT study: long-term imaging assessment. Neurology 60:A298 (Abstract)
23.
Zurück zum Zitat Schwingenschuh P, Ruge D, Edwards MJ et al (2010) Distinguishing SWEDDs patients with asymmetric resting tremor from Parkinson’s disease: a clinical and electrophysiological study. Mov Disord 25:560–569PubMedCrossRef Schwingenschuh P, Ruge D, Edwards MJ et al (2010) Distinguishing SWEDDs patients with asymmetric resting tremor from Parkinson’s disease: a clinical and electrophysiological study. Mov Disord 25:560–569PubMedCrossRef
24.
Zurück zum Zitat Deuschl G, Bain P, Brin M (1998) Consensus statement of the Movement Disorder Society on Tremor. Ad Hoc Scientific Committee. Mov Disord 13(Suppl 3):2–23PubMed Deuschl G, Bain P, Brin M (1998) Consensus statement of the Movement Disorder Society on Tremor. Ad Hoc Scientific Committee. Mov Disord 13(Suppl 3):2–23PubMed
25.
Zurück zum Zitat Gibb WR, Lees AJ (1988) The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson’s disease. J Neurol Neurosurg Psychiatry 51:745–752PubMedCrossRef Gibb WR, Lees AJ (1988) The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson’s disease. J Neurol Neurosurg Psychiatry 51:745–752PubMedCrossRef
26.
Zurück zum Zitat Fahn S, Elton R, Members of the UPDRS Development Committee (1987) Unified Parkinson’s disease rating scale. In: Fahn S, Marsden D, Caine D, Goldstein M (eds) Recent developments in Parkinson’s disease. Macmillan Healthcare Information, Florham Park, p 375 Fahn S, Elton R, Members of the UPDRS Development Committee (1987) Unified Parkinson’s disease rating scale. In: Fahn S, Marsden D, Caine D, Goldstein M (eds) Recent developments in Parkinson’s disease. Macmillan Healthcare Information, Florham Park, p 375
27.
Zurück zum Zitat Chang L (1978) A method for attenuation correction in computed tomography. IEEE Trans Nucl Sci 25:638–643CrossRef Chang L (1978) A method for attenuation correction in computed tomography. IEEE Trans Nucl Sci 25:638–643CrossRef
28.
Zurück zum Zitat Asenbaum S, Pirker W, Angelberger P, Bencsits G, Pruckmayer M, Brucke T (1998) [123I]Beta-CIT and SPECT in essential tremor and Parkinson’s disease. J Neural Transm 105:1213–1228PubMedCrossRef Asenbaum S, Pirker W, Angelberger P, Bencsits G, Pruckmayer M, Brucke T (1998) [123I]Beta-CIT and SPECT in essential tremor and Parkinson’s disease. J Neural Transm 105:1213–1228PubMedCrossRef
29.
Zurück zum Zitat Huang WS, Lin SZ, Lin JC, Wey SP, Ting G, Liu RS (2001) Evaluation of early stage Parkinson’s disease with 99mTc-TRODAT-1 imaging. J Nucl Med 42:1303–1308PubMed Huang WS, Lin SZ, Lin JC, Wey SP, Ting G, Liu RS (2001) Evaluation of early stage Parkinson’s disease with 99mTc-TRODAT-1 imaging. J Nucl Med 42:1303–1308PubMed
30.
Zurück zum Zitat Scherfler C, Schwarz J, Antonini A et al (2007) Role of DAT-SPECT in the diagnostic work up of parkinsonism. Mov Disord 22:1229–1238PubMedCrossRef Scherfler C, Schwarz J, Antonini A et al (2007) Role of DAT-SPECT in the diagnostic work up of parkinsonism. Mov Disord 22:1229–1238PubMedCrossRef
31.
Zurück zum Zitat Kagi G, Bhatia KP, Tolosa E (2010) The role of DAT-SPECT in movement disorders. J Neurol Neurosurg Psychiatry 81:5–12PubMedCrossRef Kagi G, Bhatia KP, Tolosa E (2010) The role of DAT-SPECT in movement disorders. J Neurol Neurosurg Psychiatry 81:5–12PubMedCrossRef
32.
Zurück zum Zitat Deuschl G, Elble R (2009) Essential tremor–neurodegenerative or nondegenerative disease towards a working definition of ET. Mov Disord 24:2033–2041PubMedCrossRef Deuschl G, Elble R (2009) Essential tremor–neurodegenerative or nondegenerative disease towards a working definition of ET. Mov Disord 24:2033–2041PubMedCrossRef
33.
Zurück zum Zitat Mozley PD, Kim HJ, Gur RC et al (1996) Iodine-123-IPT SPECT imaging of CNS dopamine transporters: nonlinear effects of normal aging on striatal uptake values. J Nucl Med 37:1965–1970PubMed Mozley PD, Kim HJ, Gur RC et al (1996) Iodine-123-IPT SPECT imaging of CNS dopamine transporters: nonlinear effects of normal aging on striatal uptake values. J Nucl Med 37:1965–1970PubMed
34.
Zurück zum Zitat Morrish PK, Rakshi JS, Bailey DL, Sawle GV, Brooks DJ (1998) Measuring the rate of progression and estimating the preclinical period of Parkinson’s disease with [18F]dopa PET. J Neurol Neurosurg Psychiatry 64:314–319PubMedCrossRef Morrish PK, Rakshi JS, Bailey DL, Sawle GV, Brooks DJ (1998) Measuring the rate of progression and estimating the preclinical period of Parkinson’s disease with [18F]dopa PET. J Neurol Neurosurg Psychiatry 64:314–319PubMedCrossRef
35.
Zurück zum Zitat Khan NL, Graham E, Critchley P et al (2003) Parkin disease: a phenotypic study of a large case series. Brain 126:1279–1292PubMedCrossRef Khan NL, Graham E, Critchley P et al (2003) Parkin disease: a phenotypic study of a large case series. Brain 126:1279–1292PubMedCrossRef
36.
Zurück zum Zitat Barrett RE, Yahr MD, Duvoisin RC (1970) Torsion dystonia and spasmodic torticollis—results of treatment with l-dopa. Neurology 20:107–113PubMed Barrett RE, Yahr MD, Duvoisin RC (1970) Torsion dystonia and spasmodic torticollis—results of treatment with l-dopa. Neurology 20:107–113PubMed
37.
Zurück zum Zitat Coleman M (1970) Preliminary remarks on the l-dopa therapy of dystonia. Neurology 20:114–121PubMed Coleman M (1970) Preliminary remarks on the l-dopa therapy of dystonia. Neurology 20:114–121PubMed
38.
Zurück zum Zitat Hensman DJ, Bain PG (2006) Levodopa can worsen tremor associated with dystonia. Mov Disord 21:1778–1780PubMedCrossRef Hensman DJ, Bain PG (2006) Levodopa can worsen tremor associated with dystonia. Mov Disord 21:1778–1780PubMedCrossRef
39.
Zurück zum Zitat Marshall VL, Patterson J, Hadley DM, Grosset KA, Grosset DG (2006) Two-year follow-up in 150 consecutive cases with normal dopamine transporter imaging. Nucl Med Commun 27:933–937PubMedCrossRef Marshall VL, Patterson J, Hadley DM, Grosset KA, Grosset DG (2006) Two-year follow-up in 150 consecutive cases with normal dopamine transporter imaging. Nucl Med Commun 27:933–937PubMedCrossRef
40.
Zurück zum Zitat Hilker R, Klein C, Hedrich K et al (2002) The striatal dopaminergic deficit is dependent on the number of mutant alleles in a family with mutations in the parkin gene: evidence for enzymatic parkin function in humans. Neurosci Lett 323:50–54PubMedCrossRef Hilker R, Klein C, Hedrich K et al (2002) The striatal dopaminergic deficit is dependent on the number of mutant alleles in a family with mutations in the parkin gene: evidence for enzymatic parkin function in humans. Neurosci Lett 323:50–54PubMedCrossRef
Metadaten
Titel
The role of 123I-FP-CIT-SPECT in the differential diagnosis of Parkinson and tremor syndromes: a critical assessment of 125 cases
verfasst von
Friederike Sixel-Döring
Knut Liepe
Brit Mollenhauer
Ellen Trautmann
Claudia Trenkwalder
Publikationsdatum
01.12.2011
Verlag
Springer-Verlag
Erschienen in
Journal of Neurology / Ausgabe 12/2011
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-011-6076-z

Weitere Artikel der Ausgabe 12/2011

Journal of Neurology 12/2011 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Nicht Creutzfeldt Jakob, sondern Abführtee-Vergiftung

29.05.2024 Obstipation Nachrichten

Eine ältere Frau trinkt regelmäßig Sennesblättertee gegen ihre Verstopfung. Der scheint plötzlich gut zu wirken. Auf Durchfall und Erbrechen folgt allerdings eine Hyponatriämie. Nach deren Korrektur kommt es plötzlich zu progredienten Kognitions- und Verhaltensstörungen.

Sozialer Aufstieg verringert Demenzgefahr

24.05.2024 Demenz Nachrichten

Ein hohes soziales Niveau ist mit die beste Versicherung gegen eine Demenz. Noch geringer ist das Demenzrisiko für Menschen, die sozial aufsteigen: Sie gewinnen fast zwei demenzfreie Lebensjahre. Umgekehrt steigt die Demenzgefahr beim sozialen Abstieg.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Was nützt die Kraniektomie bei schwerer tiefer Hirnblutung?

17.05.2024 Hirnblutung Nachrichten

Eine Studie zum Nutzen der druckentlastenden Kraniektomie nach schwerer tiefer supratentorieller Hirnblutung deutet einen Nutzen der Operation an. Für überlebende Patienten ist das dennoch nur eine bedingt gute Nachricht.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.